Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Pethidinic acid: corroboration of a doctor's denial of pethidine re-use.

Lewis J, Shimmon R, Fu S.

J Anal Toxicol. 2013 Apr;37(3):179-81. doi: 10.1093/jat/bkt003. Epub 2013 Feb 5.

PMID:
23386323
2.

Investigation of the Urinary excretion of pethidine and five of its metabolites in man using selected ion monitoring.

Lindberg C, Bondesson U, Hartvig P.

Biomed Mass Spectrom. 1980 Feb;7(2):88-92.

PMID:
7407337
3.

Determination of pethidine and its major metabolites in human urine by gas chromatography.

Chan K, Lau OW, Wong YC.

J Chromatogr. 1991 Apr 19;565(1-2):247-54.

PMID:
1874871
4.

Distinguishing heroin abuse from codeine administration in the urine of Chinese people by UPLC-MS-MS.

Bu J, Zhan C, Huang Y, Shen B, Zhuo X.

J Anal Toxicol. 2013 Apr;37(3):166-74. doi: 10.1093/jat/bks093. Epub 2013 Jan 12.

PMID:
23316032
5.

Sensitive determination of pethidine in body fluids by gas chromatography-tandem mass spectrometry.

Ishii A, Tanaka M, Kurihara R, Watanabe-Suzuki K, Kumazawa T, Seno H, Suzuki O, Katsumata Y.

J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 15;792(1):117-21.

PMID:
12829004
6.

Biotransformation of pethidine: a comparative study of 24 h urine in three ethnic groups.

Houghton IT, Chan K, Wong YC, Leung DH, Aun CS.

Eur J Drug Metab Pharmacokinet. 1993 Jul-Sep;18(3):285-8.

PMID:
8149948
8.

Comparison of renal excretion of pethidine (meperidine) and its metabolites in old and young patients.

Odar-Cederlöf I, Boréus LO, Bondesson U, Holmberg L, Heyner L.

Eur J Clin Pharmacol. 1985;28(2):171-5.

PMID:
3987796
9.

A leader in the field... .

DeVito RA Jr.

J Opioid Manag. 2015 Jan-Feb;11(1):6. No abstract available.

PMID:
25881374
10.

Family physicians' proficiency in urine drug test interpretation.

Reisfield GM, Webb FJ, Bertholf RL, Sloan PA, Wilson GR.

J Opioid Manag. 2007 Nov-Dec;3(6):333-7.

PMID:
18290585
11.

Evaluation of buprenorphine LUCIO immunoassay versus GC-MS using urines from a workplace drug testing program.

Alves MN, Piccinotti A, Tameni S, Polettini A.

J Anal Toxicol. 2013 Apr;37(3):175-8. doi: 10.1093/jat/bkt006. Epub 2013 Feb 13.

PMID:
23408251
12.
13.

A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management.

McCarberg BH.

Postgrad Med. 2011 Nov;123(6):124-31. doi: 10.3810/pgm.2011.11.2502. Review.

PMID:
22104461
14.

Factors influencing the excretion and relative physiological availability of pethidine in man.

Chan K, Kendall MJ, Wells WD, Mitchard M.

J Pharm Pharmacol. 1975 Apr;27(4):235-41.

PMID:
239115
15.

Does therapeutic use of tapentadol cause false-positive urine screens for methadone or opiates?

Mullins ME, Hock K, Scott MG.

Clin Toxicol (Phila). 2015 Jun;53(5):493-4. doi: 10.3109/15563650.2015.1020114. No abstract available.

PMID:
25951899
17.

Urinary excretion and metabolism of pethidine and norpethidine in the newborn.

Hogg MI, Wiener PC, Rosen M, Mapleson WW.

Br J Anaesth. 1977 Sep;49(9):891-9.

PMID:
20914
18.

Using urine drug testing to support healthy boundaries in clinical care.

Heit HA, Gourlay DL.

J Opioid Manag. 2015 Jan-Feb;11(1):7-12. doi: 10.5055/jom.2015.0247. Review.

PMID:
25750160
19.

FDA/DEA/PDMP/UDT: alphabet soup or sensible and integrated risk management?

Passik SD, Kirsh KL, Twillman RK.

J Opioid Manag. 2015 Jan-Feb;11(1):77-81. doi: 10.5055/jom.2015.0255.

PMID:
25750168
20.

Choosing the right laboratory: a review of clinical and forensic toxicology services for urine drug testing in pain management.

Reisfield GM, Goldberger BA, Bertholf RL.

J Opioid Manag. 2015 Jan-Feb;11(1):37-44. doi: 10.5055/jom.2015.0250. Review.

PMID:
25750163

Supplemental Content

Support Center